All News

Mifepristone via mail order and telehealth may continue after a Supreme Court ruling kept access in place while a lawsuit progresses.

Sameena Rahman, MD, FACOG, highlights that renaming PCOS to PMOS is vital for recognizing the condition as a systemic metabolic disorder rather than a simple ovarian issue.

A randomized clinical trial of 143 childbearing physicians found that a package including smart technology and mentorship significantly limited the rise of postpartum burnout.

“For families facing the fear of preterm birth, the absence of effective treatments for microbiome imbalance in the reproductive tract is devastating,” said Lynne Sykes, MD.

“The data show that Tdap vaccination during pregnancy is an effective way to protect infants from a serious disease at a time when they are most at risk," said Rochelle Walensky, MD, MPH.

Daré Bioscience reported that 1789 menstrual cycles of data have been reviewed for Ovaprene, with the DSMB recommending that the trial proceed without modifications.

Eduardo Lara-Torre, MD, FACOG, emphasizes that pediatric and adolescent gynecology provides a critical bridge to ensure young patients do not lose access to care as they transition to adult providers.

The vaginal insert will be available starting May 19, 2026.

According to a publication in The Lancet, a multistep process was used to generate a new name to avoid misleading references to ovarian cysts while accurately reflecting the condition's diverse features.

Eduardo Lara-Torre, MD, FACOG, explains that the unbundling of obstetric codes on January 1, 2027, will allow physicians to bill for each visit individually rather than receiving a single bundled payment.

Members of the BillionToOne team joined us at ACOG to discuss the launch of the new Unity Confirm fetal cell-based test for confirmation of high-risk prenatal screening results.

The FDA released final guidance on post-approval pregnancy safety studies to improve how clinicians evaluate the risks of drugs and biologics during pregnancy.

At ACOG 2026, we spoke with Akiva Novetsky, MD, MS, and Kimberly Gecsi, MD, about recent updates to cervical cancer screening guidelines.

According to Erick Holder, MD, AI tools can help combat medical misinformation by directing patients toward scientific research and board-certified specialists.

The comprehensive review found no evidence linking HPV vaccination to neurological conditions or adverse pregnancy outcomes across 20 years of data.

While neonatal outcomes remained stable, the use of piperacillin-tazobactam for chorioamnionitis was linked to a significantly longer maternal readmission length of stay.

Following the presentation of real-world data at HRS 2026, Ridhima Kapoor, MD, details the importance of using continuous 14-day ECG patches to capture arrhythmia burden in pregnant populations.

Take a look back at our coverage (so far) of the 2026 ACOG meeting in Washington, DC

The review of over 120 studies published since 2024 found no credible evidence linking HPV vaccination to serious adverse pregnancy outcomes or other long-term health risks.

Per CNN, Alito’s order is in effect until May 11, with responses to the case requested by Thursday, May 7.

At ACOG, Julie Anderson presented data demonstrating that virtual birth planning is associated with a nearly 4-fold increase in shared decision-making for high-risk patients.

Meaningful improvements in gynecologic care for LGBTQ patients require both environmental changes—inclusive waiting rooms, trained front desk staff, flexible scheduling—and clinical recalibration, including routine screening for contraceptive needs and menopausal symptoms regardless of gender identity or presentation.

Pelin Batur, MD, emphasizes that half of patients are unsatisfied with their sexual health and clinicians should normalize these concerns through simple, open-ended questions.

The court reinstated a nationawide requirement that abortion pills be obtained in person.

Jill Liss, MD, MSCP, FACOG, outlines aspects of hormonal and non-hormonal treatments for vasomotor symptoms.

During clinical validation done by the company, Unity Confirm demonstrated 100% concordance with known fetal outcomes and invasive diagnostic results in 16 samples.

In this discussion from ACOG's 75th Annual Meeting, Genevieve Neal-Perry, MD, PhD, explains how elinzanetant has impacted patients since it's approval in October 2025.

Molly Dickinson, DO, describes a rare case where a 22-week uterine rupture was repaired allowing the pregnancy to continue to a successful 32-week delivery.